Business Context and Reporting Period
Company: Chemical & Mining Co of Chile Inc (SQM)
Filing Type: Form 6-K (Earnings Release)
Reporting Period: Three months ended March 31, 2025 (1Q2025)
Release Date: May 27, 2025
SQM is a global producer of lithium, iodine, and specialty plant nutrition products. The company reported a return to profitability in 1Q2025, contrasting sharply with a significant loss in the prior year period driven by a one-time tax adjustment.
Key Financial Metrics
| Metric (US$ Millions) | 1Q2025 | 1Q2024 |
|---|---|---|
| Total Revenues | 1,036.6 | 1,084.5 |
| Gross Profit | 304.7 | 368.5 |
| Gross Margin | 29.4% | 34.0% |
| Net Income | 137.5 | (869.5) |
| Net Income Per Share | $0.48 | $(3.04) |
| Adjusted EBITDA | 359.6 | 403.6 |
| Adjusted EBITDA Margin | 34.7% | 37.2% |
| Cash and Equivalents | 1,656.1 | N/A |
| Total Debt (Short + Long Term) | 4,666.6 | N/A |
| Liquidity Ratio | 2.9 | N/A |
Material Changes vs. Prior Period
- Profitability Turnaround: Net income swung from a loss of $869.5 million in 1Q2024 to a profit of $137.5 million in 1Q2025. The 1Q2024 loss was primarily due to a one-time income tax expense adjustment of $1,097.6 million related to the specific mining tax for lithium.
- Revenue Decline: Total revenues decreased 4.4% year-over-year to $1,036.6 million, driven by lower lithium prices and reduced potassium sales volumes.
- Lithium Segment: Revenues fell 8.1% to $502.9 million despite a record 27% increase in sales volumes (55.0k MT vs 43.5k MT). This indicates a significant decline in average realized prices.
- Iodine Segment: Revenues increased 6.2% to $255.0 million, driven by record-high sales prices averaging $71.4/kg, despite a slight 4% drop in volumes.
- Potassium Segment: Revenues dropped 33.2% to $42.5 million due to a 38% volume decrease, as production was prioritized for internal use in the Specialty Plant Nutrition line.
Guidance, Outlook, and Management Commentary
- Lithium Outlook: Management expects lower realized prices in 2Q2025 due to market oversupply, despite strong demand growth from electric vehicles and energy storage. The Mount Holland refinery in Australia is on track to deliver first product in the upcoming months.
- Iodine Outlook: Prices are expected to remain stable at elevated levels. The company anticipates steady demand growth of 1-2% annually. Construction of the seawater pipeline is progressing to unlock future capacity.
- Specialty Plant Nutrition: Prices for potassium chloride and nitrate are under upward pressure due to market shortages. The company expects to maintain stable sales volumes.
- Strategic Shift: SQM is reducing brine extraction to prioritize high-lithium-content brines, which will continue to limit potassium sales volumes in 2025.
Investor Verification Checklist
- Tax Adjustment Impact: Verify the non-recurring nature of the $1,097.6 million tax expense in 1Q2024 to accurately assess normalized earnings trends.
- Lithium Price Trajectory: Monitor spot and contract lithium prices in 2Q2025 to validate management's forecast of lower realized prices amidst oversupply.
- Mount Holland Progress: Track the commissioning timeline of the Mount Holland refinery and the ramp-up of spodumene concentrate sales.
- Debt Servicing: Review the increase in net financial expenses ($34.3M in 1Q2025 vs $20.5M in 1Q2024) and total debt levels ($4.67B) relative to cash flow generation.
- Seawater Pipeline: Assess the timeline for the seawater pipeline completion, which is critical for future iodine capacity expansion.